.png)
SCROLL
However, technical language often used to discuss innovative science can feel cold, clinical, and be difficult to understand.
What should leave audiences eager to learn more about your therapeutics, products, or technology instead falls short and can drastically affect company sales and acquisition.
.png)
your science can make an impact.
Learn how we helped Amytrx Therapeutics.
learn how we TRANSLATE your discoveries
Is your breakthrough telling your story?
Is your story advancing quality science?
_edited_edite.png)
_edited_edite.png)
_edited_edite.png)
_edited.png)
"For the nation to capitalize on the rapidly growing efforts of entrepreneurs in the region, we must have knowledgeable science and communications professionals to advise and transform scientific innovation into successful enterprises. Validity Science Communications is positioned and committed to fulfilling this need."
- Ed Pershing
Founder of Provectus Biopharmaceuticals
"Validity Science Communications has played a pivotal role in navigating Amytrx Therapeutics out of stealth mode and into the public eye. They have a comprehensive understanding of our novel scientific technology that allows them to collaborate with accuracy on various projects, ranging from marketing and communications to investor relations. We are pleased with our partnership and highly recommend them and their dedication to rapidly respond to evolving industry trends."
- Dr. Matthew A. Gonda
CEO, Amytrx Therapeutics
"Validity Science Communications has always delivered high-caliber work bringing the science and technology knowledge of our unique space to the masses."
- Ally Perlina
Chief Science Officer
at CureMatch Inc
who we work with
